A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL

BACKGROUND: Peripheral T‐cell lymphomas (PTCLs) are a heterogeneous group of neoplasms characterized by a poor prognosis. Histone deacetylase (HDAC) inhibitors have emerged as novel therapeutic agents for PTCLs. In this study, we aimed to explore the immunomodulatory effect of the HDAC inhibitor chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Chong, Hu, Shaoxuan, Luo, Mingjie, Chen, Chong, Wang, Wei, Zhang, Wei, Zhou, Daobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204089/
https://www.ncbi.nlm.nih.gov/pubmed/34141623
http://dx.doi.org/10.3389/fonc.2021.682436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204089/
https://www.ncbi.nlm.nih.gov/pubmed/34141623
http://dx.doi.org/10.3389/fonc.2021.682436

Ejemplares similares